| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA3350037 | Octreotide | INH | 0 | ALA3227458 | Dose-dependent effect | % | Homo sapiens | ||||
| 2. | ALA3350037 | Octreotide | INH | 0 | ALA3227457 | Dose-dependent effect | % | Homo sapiens | ||||
| 3. | ALA3350037 | Octreotide | INH | 0 | ALA3227456 | Dose-dependent effect | % | Homo sapiens | ||||
| 4. | ALA3350037 | Octreotide | INH | 0 | ALA3227455 | Dose-dependent effect | % | Homo sapiens | ||||
| 5. | ALA3350037 | Octreotide | INH | 0 | ALA3227454 | Dose-dependent effect | % | Homo sapiens | ||||
| 6. | ALA3350037 | Octreotide | Ki | = | 67.6 | nM | ALA3227458 | 7.17 | nM | Homo sapiens | ||
| 7. | ALA3350037 | Octreotide | Ki | = | 398 | nM | ALA3227457 | 6.40 | nM | Homo sapiens | ||
| 8. | ALA3350037 | Octreotide | Ki | = | 13.2 | nM | ALA3227456 | 7.88 | nM | Homo sapiens | ||
| 9. | ALA3350037 | Octreotide | Ki | = | 0.645 | nM | ALA3227455 | 9.19 | nM | Homo sapiens | ||
| 10. | ALA3350037 | Octreotide | Ki | = | 224 | nM | ALA3227454 | 6.65 | nM | Homo sapiens | ||
| 11. | ALA3350037 | Octreotide | Hepatotoxicity (mechanism) | 0 | ALA3137740 | Dose-dependant | ||||||
| 12. | ALA3350037 | Octreotide | Hepatotoxicity (time to onset) | 0 | ALA3137739 | 1 day - 14 months | ||||||
| 13. | ALA3350037 | Octreotide | Hepatotoxicity (comment) | 0 | ALA3137738 | BOUE_BILIAIRE LITHIASE | ||||||
| 14. | ALA3350037 | Octreotide | Hepatotoxicity (successful reintroduction) | 0 | ALA3137737 | yes | ||||||
| 15. | ALA3350037 | Octreotide | Hepatotoxicity (animal toxicity known) | 0 | ALA3137736 | |||||||
| 16. | ALA3350037 | Octreotide | Hepatotoxicity (benign tumour) | = | 0 | ALA3137735 | references out of a total of 89 | |||||
| 17. | ALA3350037 | Octreotide | Hepatotoxicity (malignant tumour) | = | 0 | ALA3137734 | references out of a total of 89 | |||||
| 18. | ALA3350037 | Octreotide | Hepatotoxicity (steatosis) | = | 0 | ALA3137733 | references out of a total of 89 | |||||
| 19. | ALA3350037 | Octreotide | Hepatotoxicity (association with vascular disease) | = | 0 | ALA3137732 | references out of a total of 89 | |||||
| 20. | ALA3350037 | Octreotide | Hepatotoxicity (granulomatous hepatitis) | = | 0 | ALA3137731 | references out of a total of 89 |
The page will load shortly, Thanks for your patience!